Documente Academic
Documente Profesional
Documente Cultură
and NKT function leads to enhanced cellular immune tumor-response and higher patient survival rates. Keys to Envita's AAIT Uniqueness 1) Envita's protocol for AAIT is primed to optimize the expansion of natural killer cells the single most potent cancer fighting component of the cellular immune system. Most immune therapies do, in fact, include natural killer cells, yet those that do, simply expand them in minimal amounts with little activation. 2) Envita's AAIT protocol requires only four to five weeks to grow your cells, so you can, with a degree of certainty, experience benefits within short duration - while other immunotherapy approaches call to administer just 100-200 million cells per treatment, Envita delivers roughly 100 times as many during the sojourn of treatment. 3) Stockpilesof published studies convey the effects of adoptive immune therapy in cancer patients, wherein Envita has identified and improved upon the very best. Company protocol demands the highest level of procedure for the expansion and application of cells for each immunotherapy treatment. 4) Unlike other publications regarding immune therapies, Envita's AAIT immunotherapy endorses the only one that can be used as a stand-alone. Moreover, it may also be administered in conjunction with other therapies to enhance the cells effects in patients an enviable benefit. Envita's AAIT immunotherapy is not focused solely on expanding cells in the laboratory: rather, our aim also includes keeping them active, until which time, they are reintroduced into the patients body. 5) Envitas AAIT immunotherapy unleashes far greater tumor destruction, or cytotoxicity than that of other well-regarded cancer cell vaccines / immunotherapy treatments found randomly throughout the world. In essence, this indicates that Envitas activated natural killer cells in AAIT deliver considerably higher tumor obliteration. 6) In summation, the most direct manner with which to contrast Envitas proprietary immunotherapy against the others includes its: a. Quality - based on cytoxicity (how much tumor the immune system can marginalize). Envitas AAIT immunotherapy consistently delivers significantly greater tumor kill. b. Quantity (how many cells you get back) Envitas AAIT immunotherapy battles with 100 times the cell dosage than those others. c. Sterility (quality control measures) Envita AAIT immunotherapy is completely free of contaminants. Any questions concerning Envita's AAITimmunotherapy may be addressed during consultation with Envita's superb team of physicians and patient educators. This immunotherapy is offered at Envitas international cancer center in Mexico.